Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism

Journal of Thrombosis and Haemostasis : JTH
Mark MonahanSue Jowett

Abstract

Essentials Correct duration of treatment after a first unprovoked venous thromboembolism (VTE) is unknown. We assessed when restarting anticoagulation was worthwhile based on patient risk of recurrent VTE. When the risk over a one-year period is 17.5%, restarting is cost-effective. However, sensitivity analyses indicate large uncertainty in the estimates. Background Following at least 3 months of anticoagulation therapy after a first unprovoked venous thromboembolism (VTE), there is uncertainty about the duration of therapy. Further anticoagulation therapy reduces the risk of having a potentially fatal recurrent VTE but at the expense of a higher risk of bleeding, which can also be fatal. Objective An economic evaluation sought to estimate the long-term cost-effectiveness of using a decision rule for restarting anticoagulation therapy vs. no extension of therapy in patients based on their risk of a further unprovoked VTE. Methods A Markov patient-level simulation model was developed, which adopted a lifetime time horizon with monthly time cycles and was from a UK National Health Service (NHS)/Personal Social Services (PSS) perspective. Results Base-case model results suggest that treating patients with a predicted 1 year VTE ri...Continue Reading

References

Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Sep 9, 1996·Archives of Internal Medicine·B F GageD K Owens
Jun 20, 2003·Circulation·Richard H White
Oct 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·R FogelholmS Avikainen
May 19, 2006·Journal of Thrombosis and Haemostasis : JTH·S ShrivastavaM Cushman
May 19, 2007·BMJ : British Medical Journal·David A Fitzmaurice, Ellen Murray
Aug 25, 2007·BMJ : British Medical Journal·John ApplebyDavid Parkin
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Aug 27, 2010·Journal of Thrombosis and Haemostasis : JTH·C KearonUNKNOWN Subcommittee on Control of Anticoagulation of the SSC of the ISTH
Dec 4, 2010·The Journal of the Royal College of Physicians of Edinburgh·T M HyersI A Campbell
Dec 7, 2010·Lancet·Paul Alexander KyrleSabine Eichinger
Feb 18, 2011·Journal of Thrombosis and Thrombolysis·Marco P Donadini, Walter Ageno
Jun 29, 2012·BMJ : British Medical Journal·Lee-Yee ChongUNKNOWN Guideline Development Group
Nov 20, 2012·Stroke; a Journal of Cerebral Circulation·Ramon Luengo-FernandezUNKNOWN Oxford Vascular Study

❮ Previous
Next ❯

Citations

Apr 5, 2019·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Ira L LeedsBashar Safar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.